home

investor relations
investor relations
     
  Investor Relations  
  General Information  
     
  ULURU Inc. is committed to developing and commercializing a broad range of innovative wound care and muco-adhesive film products, based on our patented Nanoflex™ and OraDisc™ technologies, with the aim of improving outcomes for patients, health care professionals and providers.  
     
  Streaming Audio  
  Streaming audio is available of financial results. Click here to listen to recorded meetings.  
     
  Stock Information  
  ULURU is traded on the NYSE Amex, trading symbol ULU. Click here for current information.  
     
  SEC Documents  
   
     
  Company Annual Report  
   
     
  Proxy Materials  
   
     
  Request an Investor Kit  
 

Investor Kits are available for download Click here to email your request.

     

 

 

© 2010 ULURU Inc.

Latest News
ULURU Inc. developed and commercializes Altrazeal™, a transforming powder dressing with proprietary Nanoflex™ technology, for the management of exuding wounds.
Visit
www.altrazeal.com
for clinical case studies, patient testimonials, application guidelines, and much more…